Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review
- PMID: 23462530
- DOI: 10.1016/j.tmrv.2013.01.002
Use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review
Abstract
The use of prothrombin complex concentrates (PCCs) and fibrinogen concentrates (FIBCs) to achieve hemostasis in the perioperative setting as alternatives to allogeneic blood products remains controversial. To examine the efficacy and safety of PCCs and FIBCs, we conducted a systematic review-in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis statement-to compare the use of these transfusion alternatives in bleeding surgical patients. We performed a literature search of English articles published between July 1997 and July 2012 in MEDLINE via PubMed, The Cochrane Library, and CINAHL. Five randomized trials and 15 nonrandomized studies with a comparator group were included in the final review. Studies were sorted into 1 of the following 3 clinical settings: cardiac surgery, non-cardiac surgery, and reversal of warfarin anticoagulation. Risk of bias was assessed using the Cochrane risk of bias tool. With the exception of 2 randomized controlled trials, the existing body of literature on the use of PCCs and FIBCs in the perioperative setting was assessed to have a high degree of methodological bias. Overall, prospective studies in the cardiac surgery grouping suggested that patients receiving FIBC and/or PCCs required less allogeneic blood transfusion and had less chest tube drainage. In studies of warfarin reversal, PCCs more rapidly corrected the International Normalized Ratio compared to plasma; however, in the setting of intracranial hemorrhage, functional outcomes were poor regardless of the reversal strategy. With regards to safety outcomes, reporting was not uniform and raises concerns of underreporting. Adequately powered, methodologically sound trials would be required for more definitive conclusions to be drawn about the efficacy of PCCs and FIBC over conventional blood components for the treatment of perioperative coagulopathy in bleeding patients.
Copyright © 2013 Elsevier Inc. All rights reserved.
Comment in
-
The authors' reply.Transfus Med Rev. 2014 Jan;28(1):32. doi: 10.1016/j.tmrv.2013.10.005. Epub 2013 Nov 5. Transfus Med Rev. 2014. PMID: 24333032 No abstract available.
-
The factor in the license: in reference to "use of prothrombin complex concentrates and fibrinogen concentrates in the perioperative setting: a systematic review".Transfus Med Rev. 2014 Jan;28(1):31. doi: 10.1016/j.tmrv.2013.10.004. Epub 2013 Nov 5. Transfus Med Rev. 2014. PMID: 24342370 No abstract available.
Similar articles
-
Perioperative Use of Coagulation Factor Concentrates in Patients Undergoing Cardiac Surgery.J Cardiothorac Vasc Anesth. 2017 Oct;31(5):1810-1819. doi: 10.1053/j.jvca.2017.05.017. Epub 2017 May 10. J Cardiothorac Vasc Anesth. 2017. PMID: 28838728 Review.
-
Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.Anesth Analg. 2016 May;122(5):1287-300. doi: 10.1213/ANE.0000000000001188. Anesth Analg. 2016. PMID: 26983050 Free PMC article. Review.
-
Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.Clin Neurol Neurosurg. 2013 Jun;115(6):770-4. doi: 10.1016/j.clineuro.2012.07.006. Epub 2012 Jul 24. Clin Neurol Neurosurg. 2013. PMID: 22835715
-
Perioperative use of prothrombin complex concentrates.Minerva Anestesiol. 2012 Mar;78(3):358-68. Minerva Anestesiol. 2012. PMID: 22357373 Review.
-
Perioperative hemostatic management of patients treated with vitamin K antagonists.Anesthesiology. 2008 Nov;109(5):918-26. doi: 10.1097/ALN.0b013e3181895bd8. Anesthesiology. 2008. PMID: 18946305 Review.
Cited by
-
Fibrinogen Early In Severe Trauma studY (FEISTY): results from an Australian multicentre randomised controlled pilot trial.Crit Care Resusc. 2023 Oct 18;23(1):32-46. doi: 10.51893/2021.1.OA3. eCollection 2021 Mar. Crit Care Resusc. 2023. PMID: 38046391 Free PMC article.
-
Prothrombin complex concentrate in cardiac surgery for the treatment of coagulopathic bleeding.Cochrane Database Syst Rev. 2022 Nov 21;11(11):CD013551. doi: 10.1002/14651858.CD013551.pub2. Cochrane Database Syst Rev. 2022. PMID: 36408876 Free PMC article. Review.
-
Early administration of fibrinogen concentrate in patients with polytrauma with thromboelastometry suggestive of hypofibrinogenemia: A randomized feasibility trial.Clinics (Sao Paulo). 2021 Nov 8;76:e3168. doi: 10.6061/clinics/2021/e3168. eCollection 2021. Clinics (Sao Paulo). 2021. PMID: 34755760 Free PMC article. Clinical Trial.
-
Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease.Semin Hematol. 2020 Apr;57(2):73-82. doi: 10.1053/j.seminhematol.2020.07.006. Epub 2020 Jul 27. Semin Hematol. 2020. PMID: 32892846 Free PMC article. Review.
-
Essential Role of Patient Blood Management in a Pandemic: A Call for Action.Anesth Analg. 2020 Jul;131(1):74-85. doi: 10.1213/ANE.0000000000004844. Anesth Analg. 2020. PMID: 32243296 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical